Open Lung Maneuvers During High Frequency Oscillatory Ventilation in Preterm Infants

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeUp to 8
SponsorMedical University of Vienna

About this trial

To assess whether stepwise oxygenation-guided lung recruitment at regular intervals reduces the oxygen saturation index (OSI = Mean Airway Pressure × Fraction of inspired Oxygen × 100 / peripheral Oxygen Saturation, OSI = MAPxFiO2x100/SpO2) averaged over high frequency oscillation ventilation (HFOV) time in extremely preterm infants.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

born below 28 weeks of gestational age

not older than 29 weeks of postmenstrual age

receive HFOV

Disqualifiers

known congenital anomalies of the heart, of the lung, and/or of the central nervous system

known chromosomal abnormalities

participation in other intervention trials

Trial design

Design model

Parallel

Treatments tested in this trial

  • regular lung recruitment

    Procedure/Surgery

    stepwise oxygenation-guided lung recruitment at regular (twelve hours) intervals during high frequency oscillation ventilation

Treatment groups

36 Participants
are divided into 2 treatment groups
Group A: InterventionExperimental treatment 1 intervention
Group B: ControlNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

HFOV oxygen saturation index

oxygen saturation index averaged over high frequency oscillation ventilation for not more than seven consecutive days

Time frame
through study completion, an average 10 weeks

Secondary outcomes

1

bronchopulmonary dysplasia

respiratory support at 36 weeks postmenstrual age

Time frame
through study completion, an average 10 weeks
2

days of ventilation

days on conventional and high frequency oscillation ventilation

Time frame
through study completion, an average 10 weeks
3

overall oxygen saturation index

oxygen saturation index averaged over ventilation time

Time frame
through study completion, an average 10 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.